Smith & Nephew SNATS (NYSE:SNN) Downgraded by Wall Street Zen to “Buy”

Wall Street Zen lowered shares of Smith & Nephew SNATS (NYSE:SNN) from a strong-buy rating to a buy rating in a research note issued to investors on Saturday.

Other equities analysts have also recently issued research reports about the stock. Kepler Capital Markets upgraded shares of Smith & Nephew SNATS to a “strong-buy” rating in a research report on Monday, November 17th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research note on Wednesday, January 21st. Royal Bank Of Canada downgraded Smith & Nephew SNATS from an “outperform” rating to a “sector perform” rating in a report on Monday, December 15th. Finally, Canaccord Genuity Group dropped their target price on Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating for the company in a report on Tuesday, November 11th. One equities research analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $35.75.

Smith & Nephew SNATS Stock Up 1.2%

SNN stock opened at $36.10 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40. Smith & Nephew SNATS has a one year low of $23.91 and a one year high of $38.79. The company’s 50 day moving average price is $33.77 and its two-hundred day moving average price is $34.94.

Institutional Trading of Smith & Nephew SNATS

Large investors have recently modified their holdings of the business. NewEdge Advisors LLC raised its position in Smith & Nephew SNATS by 18.7% during the 4th quarter. NewEdge Advisors LLC now owns 7,571 shares of the medical equipment provider’s stock valued at $248,000 after purchasing an additional 1,192 shares during the last quarter. XTX Topco Ltd increased its stake in shares of Smith & Nephew SNATS by 165.1% during the fourth quarter. XTX Topco Ltd now owns 49,063 shares of the medical equipment provider’s stock valued at $1,610,000 after buying an additional 30,553 shares during the period. Voloridge Investment Management LLC bought a new position in shares of Smith & Nephew SNATS during the fourth quarter valued at approximately $330,000. OLD Mission Capital LLC purchased a new stake in Smith & Nephew SNATS in the fourth quarter worth $7,438,000. Finally, Millennium Management LLC lifted its stake in Smith & Nephew SNATS by 413.7% in the fourth quarter. Millennium Management LLC now owns 337,623 shares of the medical equipment provider’s stock worth $11,077,000 after acquiring an additional 271,894 shares during the period. 25.64% of the stock is owned by institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.